EDIT vs ROST · rev $32.3M vs P/E 21, rev $21.13B
Editas Medicine Inc (EDIT) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
EDIT currently screens at market cap $375.2M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the EDIT and ROST stock pages for the full models.
Not investment advice.